PCDH19 and nervous system disorder: Additionally, in view of the reduction in allopregnanololone and other steroid levels in patients with protocadherin 19 (PCDH19)—female limited epilepsy [87], trial is currently ongoing to evaluate if ganaxolone may be beneficial in patients with this rare neurological disorder [88].